Full text loading...
- ISSN: 1871-529X
- E-ISSN: 2212-4063
-
Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis
- Source: Cardiovascular & Haematological Disorders - Drug Targets, Volume 9, Issue 2, Jun 2009, p. 141 - 148
-
- 01 Jun 2009
Abstract
Proteomics applications to study the molecular effects of drug administration (pharmacoproteomics) on left ventricular hypertrophy (LVH) and atherosclerosis are here reviewed. In most cases, an absence of complete normalization after treatment is revealed, in contrast to what is reported by classical approaches.
© Bentham Science Publishers